
Labstep
Labstep captures real time scientific process data to provide an internally shareable timeline of a lab's activity.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
N/A | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 Valuation: €0.0 | round | |
* | N/A | Acquisition | |
Total Funding | 000k |




Related Content
Labstep operates a cloud-based R&D platform designed to streamline the research process for scientists by integrating an Electronic Laboratory Notebook (ELN), Laboratory Information Management System (LIMS), and other research management tools into a single environment. The company was founded in 2013 by Jake Schofield and Jan Domanski. Schofield's background in biomedical sciences and his subsequent experiences in both academic and commercial research labs exposed him to the frustrations of traditional, paper-based record-keeping and clunky existing software. This first-hand experience was the impetus for creating a more intuitive and efficient digital solution for scientists. The initial prototype was developed at the University of Oxford in 2015, and after receiving investment from Seedcamp in 2017, the platform was officially launched.
The company's core offering is its ELN platform, which serves as a digital notebook for scientists to plan, execute, and document experiments. It allows for the real-time capture of structured data, moving away from manual and delayed documentation. Key features include interactive, version-controlled protocols, inventory and order management, and the ability to connect with lab instruments and software through an open API. This integration automates data collection, tracks sample lineage, and manages resources, aiming to reduce administrative time and improve data integrity. The platform is accessible on desktop, tablet, and mobile devices, facilitating use in various lab environments. Labstep targets a broad market, including academic institutions, biotech startups, and large pharmaceutical companies. Its business model operates on a freemium basis, offering a free version for academics and tiered subscription plans (Pro and Enterprise) for commercial organizations with more advanced needs.
In August 2023, Labstep was acquired by STARLIMS, a provider of enterprise informatics solutions. The deal's value was not disclosed. This strategic acquisition integrated Labstep's user-friendly, cloud-native ELN with STARLIMS's comprehensive LIMS capabilities. The combination aims to provide a seamless, connected platform that supports the entire product lifecycle, from early-stage R&D and ideation, where Labstep excels, through to manufacturing and quality control, which is STARLIMS's traditional strength. For STARLIMS, the acquisition added a modern, SaaS-based ELN to its portfolio, addressing customer demand for a unified system that bridges the gap between research and production.
Keywords: Electronic Laboratory Notebook, ELN, LIMS, R&D platform, scientific research software, laboratory management, data capture, experiment tracking, protocol management, data integrity, intellectual property protection, life sciences, biotech, pharma, research and development, STARLIMS, Jake Schofield, lab automation, scientific collaboration, inventory management, cloud-based lab software, digital lab notebook